✦ LIBER ✦

PDB46 Cost-Effectiveness of Angiotensin Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in the Netherlands - A Markov Model

✍ Scribed by Adarkwah, C.C.; Evers, S.; Akkerman, M.; Gandjour, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Cost-Effectiveness Analysis of Angiote

✍ Panagiotis C. Stafylas; Pantelis A. Sarafidis; Dimitrios M. Grekas; Anastasios N 📂 Article 📅 2007 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 230 KB

Predictors of the progression of diabeti

✍ H. Yokoyama; O. Tomonaga; M. Hirayama; A. Ishii; M. Takeda; T. Babazono; U. Ujih 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 115 KB

Comparison of angiotensin converting enz

✍ Mahmoud A. Mansour; Hani Al-Ismaeel; Ammar C. Al-Rikabi; Othman A. Al-Shabanah 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 482 KB

139. Comparison of Angiotensin Convertin

✍ Mahmoud A. Mansour; Hani Al-Ismaeel; Ammar C. Al-Rikabi; Othman A. Al-Shabanah 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Effects of the angiotensin II type 1 rec

✍ Atsuhisa Sato; Mitsuhisa Tabata; Koichi Hayashi; Takao Saruta 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 273 KB

PDB40 THE USE OF DIABETES PREVENTION PRO

✍ S Novak; K Lawson; J Wilson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB